Vident Advisory’s DexCom DXCM Stock Holding History

Vident Advisory’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$741K	Buy	11,804 +4,751	+67%	+$331K	0.01%	1026
2025 Q4	$468K	Sell	7,053 -2,023	-22%	-$131K	﹤0.01%	1203
2025 Q3	$611K	Buy	9,076 +695	+8%	+$55K	0.01%	1087
2025 Q2	$732K	Buy	8,381 +626	+8%	+$49.1K	0.01%	867
2025 Q1	$530K	Buy	7,755 +2,538	+49%	+$207K	0.01%	1004
2024 Q4	$406K	Sell	5,217 -25,324	-83%	-$1.87M	0.01%	1051
2024 Q3	$2.05M	Buy	30,541 +25,040	+455%	+$2.06M	0.05%	380
2024 Q2	$624K	Buy	5,501 +450	+9%	+$56.9K	0.02%	787
2024 Q1	$701K	Buy	5,051 +363	+8%	+$45.6K	0.01%	687
2023 Q4	$582K	Sell	4,688 -156	-3%	-$15.9K	0.01%	720
2023 Q3	$452K	Buy	+4,844	New	+$546K	0.01%	736

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vident Advisory's DXCM Position: Q1 2026 in Review

Vident Advisory increased its DexCom (DXCM) stake by 67% in Q1 2026, buying an estimated $331K and bringing the position to 11,804 shares worth $741K. The position accounts for 0.01% of the portfolio, ranked #1026.

Vident Advisory first reported a position in DXCM in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.05M in Q3 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Vident Advisory held 11,804 shares of DexCom worth $741K as of Q1 2026.
Vident Advisory bought 4,751 DexCom shares in Q1 2026, an estimated $331K.
DexCom made up 0.01% of Vident Advisory's portfolio in Q1 2026, its #1026 holding.
Vident Advisory first reported a position in DexCom in Q3 2023 and has held it in 11 quarters since.
Vident Advisory's DexCom position peaked at $2.05M in Q3 2024.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.